Akebia Therapeutics AKBA
NASDAQ AKBA
$0.92 +0.03 (+3.37%)
At close: Sep 30, 2026 · 4:00 PM EDT

Akebia Therapeutics (AKBA) Tax Provisions (2018 - 2026)

Updated

Akebia Therapeutics (AKBA) posted Tax Provisions of $70,000 for Q2 2026, down 44.4% from the prior quarter.

Analysis

Akebia Therapeutics (AKBA) Tax Provisions (2018 - 2026) Analysis & Trends

For the trailing twelve months through Jun 30, 2026, Tax Provisions at Akebia Therapeutics was $1.82 million; for FY2025, it was $1.62 million.

  • The Q2 2026 figure stands as the lowest quarterly Tax Provisions since Q4 2019.
  • According to Business Quant data, Tax Provisions for the three prior quarters was $126,000 (Q1 2026), $1.01 million (Q4 2025) and $615,000 (Q3 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Taxes (Qtr)
1 Johnson & Johnson 638.12 Bn 556.64 Bn 17.26 Bn 1.21 Bn
2 AbbVie 462.60 Bn 435.75 Bn 12.70 Bn 662.00 Mn
3 Merck 358.70 Bn 313.13 Bn 12.21 Bn 654.00 Mn
4 Novartis Ag 272.16 Bn 228.03 Bn 11.24 Bn -1.01 Bn
5 Astrazeneca 250.36 Bn 223.92 Bn 12.86 Bn -291.00 Mn
6 Amgen 227.87 Bn 183.27 Bn 7.24 Bn 393.00 Mn
7 Gilead Sciences 184.97 Bn 159.08 Bn 6.22 Bn 242.00 Mn
8 Pfizer 162.61 Bn 109.56 Bn 10.94 Bn -407.00 Mn
9 Vertex Pharmaceuticals 132.45 Bn 104.46 Bn 2.84 Bn 292.00 Mn
10 Akebia Therapeutics 250.00 Mn -419.48 Mn 38.70 Mn 70,000.00
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 70,000.00
Mar 31, 2026 126,000.00
Dec 31, 2025 1.01 Mn
Sep 30, 2025 615,000.00
Dec 31, 2019 -1.75 Mn
Sep 30, 2019 -1.28 Mn
Jun 30, 2019 -845,000.00
Mar 31, 2019 -2.76 Mn
Dec 31, 2018 -28.34 Mn
API Access

Akebia Therapeutics Tax Provisions API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=tax-provisions&ticker=AKBA&period=max&api_key=YOUR_API_KEY